Loading…

LIGHT/TNFSF14 regulates estrogen deficiency‐induced bone loss

Bone loss induced by ovariectomy is due to the direct activity on bone cells and mesenchymal cells and to the dysregulated activity of bone marrow cells, including immune cells and stromal cells, but the underlying mechanisms are not completely known. Here, we demonstrate that ovariectomy induces th...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pathology 2020-04, Vol.250 (4), p.440-451
Main Authors: Brunetti, Giacomina, Storlino, Giuseppina, Oranger, Angela, Colaianni, Graziana, Faienza, Maria F, Ingravallo, Giuseppe, Di Comite, Mariasevera, Reseland, Janne E, Celi, Monica, Tarantino, Umberto, Passeri, Giovanni, Ware, Carl F, Grano, Maria, Colucci, Silvia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bone loss induced by ovariectomy is due to the direct activity on bone cells and mesenchymal cells and to the dysregulated activity of bone marrow cells, including immune cells and stromal cells, but the underlying mechanisms are not completely known. Here, we demonstrate that ovariectomy induces the T‐cell co‐stimulatory cytokine LIGHT, which stimulates both osteoblastogenesis and osteoclastogenesis by modulating osteoclastogenic cytokine expression, including TNF, osteoprotegerin, and the receptor activator of nuclear factor‐κB ligand (RANKL). Predictably, LIGHT‐deficient (Tnfsf14−/−) mice are protected from ovariectomy‐dependent bone loss, whereas trabecular bone mass increases in mice deficient in both LIGHT and T and B lymphocytes (Rag −/−Tnfsf14 −/−) and is associated with an inversion of the TNF and RANKL/OPG ratio. Furthermore, women with postmenopausal osteoporosis display high levels of LIGHT in circulating T cells and monocytes. Taken together, these results indicate that LIGHT mediates bone loss induced by ovariectomy, suggesting that patients with postmenopausal osteoporosis may benefit from LIGHT antagonism. © 2020 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
ISSN:0022-3417
1096-9896
DOI:10.1002/path.5385